Peter Radovich
2021
In 2021, Peter Radovich earned a total compensation of $1.8M as Chief Operating Officer at Mirum Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $946,010 |
| Salary | $425,000 |
| Stock Awards | $207,919 |
| Other | $11,600 |
| Total | $1,803,029 |
Radovich received $946K in option awards, accounting for 52% of the total pay in 2021.
Radovich also received $212.5K in non-equity incentive plan, $425K in salary, $207.9K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Peter Radovich's compensation ranked 6,447th out of 12,406 executives tracked by ExecPay. In other words, Radovich earned more than 48.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,447 out of 12,406 | 48th |
Division Manufacturing | 2,756 out of 5,492 | 50th |
Major group Chemicals And Allied Products | 1,216 out of 2,368 | 49th |
Industry group Drugs | 1,084 out of 2,089 | 48th |
Industry Pharmaceutical Preparations | 783 out of 1,536 | 49th |
Source: SEC filing on April 22, 2022.
Radovich's colleagues
We found three more compensation records of executives who worked with Peter Radovich at Mirum Pharmaceuticals in 2021.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021